Complementary Therapy with Traditional Chinese Medicine for Polycystic Ovarian Syndrome

February 2018 in “ InTech eBooks ”

Yen-Nung Liao, Wen-Long Hu, Yu-Chiang Hung

Traditional Chinese Medicine Polycystic Ovarian Syndrome PCOS clomiphene citrate metformin oral contraceptives bariatric surgery acupuncture moxibustion Jia-Wei-Xiao-Yao-San Wen-Jing-Tang TCM birth control pills

Studysummary This chapter discusses the current developments in Traditional Chinese Medicine for treating PCOS but reports no new clinical results, emphasizing the need for further research in this area. Our plain-language summary of this paper — not a Tressless recommendation.

The document from 2018 reviewed the potential of Traditional Chinese Medicine (TCM) as a complementary approach to treating Polycystic Ovarian Syndrome (PCOS), a condition affecting 5-20% of women of reproductive age globally. It detailed the various comorbidities associated with PCOS, such as obesity, insulin resistance, and cardiovascular disease, and discussed the limitations of conventional treatments like clomiphene citrate, metformin, and oral contraceptives, which can have side effects and low adherence rates. Bariatric surgery was mentioned as having some benefits but lacked evidence for fertility improvement. TCM and acupuncture were highlighted for their use in managing PCOS symptoms, with herbal formulas like Jia-Wei-Xiao-Yao-San and Wen-Jing-Tang being used to regulate menstruation and improve ovulation rates. Acupuncture and moxibustion were also noted for their potential in treating reproductive and endocrine metabolic disorders. The document concluded that while TCM and acupuncture could lead to better outcomes and reduced medical costs, more research is needed to substantiate their effectiveness as complementary therapies for PCOS.

View this study on intechopen.com →

Discuss this study in the Community →

Research cited in this study

13 / 13 results

research History of Discovery of Polycystic Ovary Syndrome

22 citations , June 2017 in “Advances in Clinical and Experimental Medicine”

This review discusses the historical understanding and evolving diagnostic criteria for polycystic ovary syndrome without presenting new clinical findings, highlighting the multifactorial nature and associated risks of the condition.

research The Pathogenesis and Treatment of Polycystic Ovary Syndrome: What’s New?

135 citations , April 2017 in “Advances in Clinical and Experimental Medicine”

This review discusses the causes, clinical implications, and treatment options for polycystic ovary syndrome and reports no new results; the authors highlight both approved and emerging therapies.

research Nutritional Management in Women with Polycystic Ovary Syndrome: A Review Study

91 citations , April 2017 in “Diabetes & Metabolic Syndrome: Clinical Research and Reviews”

This review discusses the role of dietary habits and lifestyle modifications in managing polycystic ovary syndrome and reports no clinical results; the authors emphasize the need for tailored diet therapy in affected women.

research Current Aspects of Polycystic Ovary Syndrome: A Literature Review

15 citations , December 2016 in “Revista Da Associacao Medica Brasileira”

This review examines the literature on polycystic ovary syndrome, focusing on its pathogenesis, diagnosis, and links to cardiovascular and hypertensive disorders, but presents no new clinical findings.

research Comprehensive Overview of Polycystic Ovary Syndrome

883 citations , August 2016 in “Nature Reviews Disease Primers”

This review discusses the current understanding of polycystic ovary syndrome, focusing on its epidemiology, pathophysiology, diagnosis, management, and future research directions, but reports no new clinical results.

research Genetic, Hormonal, and Metabolic Aspects of PCOS: An Update

258 citations , July 2016 in “Reproductive Biology and Endocrinology”

This abstract reviews the characteristics and health risks associated with polycystic ovary syndrome and does not report new findings, highlighting the syndrome's multifactorial nature.

research Androgen Excess: Investigations and Management

82 citations , May 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”

This article outlines the clinical features, evaluation, and treatment strategies for androgen excess in polycystic ovary syndrome, highlighting important diagnostic and management approaches but reporting no new research results.

research Diagnostic Criteria for PCOS: Is There a Need for a Rethink?

62 citations , April 2016 in “Best Practice & Research in Clinical Obstetrics & Gynaecology”

This review discusses the need to update the Rotterdam diagnostic criteria for polycystic ovarian syndrome, highlighting issues with current definitions and proposing new markers like serum anti-Müllerian hormone, but reports no new clinical results.

American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1

research American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1

343 citations , October 2015 in “Endocrine Practice”

This review discusses the diagnostic criteria and management strategies for Polycystic Ovary Syndrome (PCOS) and highlights the need for comprehensive clinical assessment, but does not report new clinical findings.

research Epidemiology, Diagnosis, and Management of Polycystic Ovary Syndrome

951 citations , December 2013 in “Clinical epidemiology”

This article reviews the prevalence, risk factors, and clinical manifestations of polycystic ovary syndrome, highlighting current treatment and management options, but reports no new research findings.

Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

research Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome Society

815 citations , April 2010 in “The Journal of Clinical Endocrinology & Metabolism”

This review examines the relationship between polycystic ovary syndrome and cardiovascular disease risk, but reports no new clinical findings; the panel calls for guidelines to prevent CVD in this population.

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

research Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

1744 citations , August 2006 in “The Journal of Clinical Endocrinology and Metabolism”

This review discusses definitions of polycystic ovary syndrome and reports no new clinical results; the authors support using modified 1990 NIH criteria and acknowledge ongoing evolution as research advances.

research Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome

4809 citations , January 2004 in “Fertility and Sterility”

This review discusses polycystic ovary syndrome, emphasizing its broad range of manifestations and associations with risks like type 2 diabetes and cardiovascular events, but reports no new clinical results.